A National Institute for Health and Care Excellence (NICE) – New guidance on the use of surrogate endpoints in cost-effectiveness analysis for use in Health Technology Assessment (HTA)
NICE collaborated with international HTA agencies from the US, Canada, Australia, the Netherlands, and Columbia to produce best practice recommendations for using surrogate endpoints in health economic models to guide HTA decisions. Surrogate endpoints are...





